Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Tuberous Sclerosis 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Glioma 2 Adenoma, Islet Cell 2 von Hippel-Lindau Disease 1 Vascular Malformations 1 Unilateral Breast Neoplasms 1 Thymus Neoplasms 1 Seizures 1 Sarcoma, Kaposi 1 Sarcoma 1 Nevus 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphangioma 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Hormone Receptor Positive Breast Cancer 1 Hemangioma 1 Hemangioendothelioma 1

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Everolimus × 90 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡